Loss of rbms1 promotes anti-tumor immunity through enabling pd-l1 checkpoint blockade in triple-negative breast cancer

HIGHLIGHTS

• who: Jinrui Zhang from the All animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee (IACUC) of Dalian Medical UniversityFor establishing tumor engraftment model, six-week-old Balb/c mice or nude mice were randomly and blindly divided into groups (five to six mice per group). Control sh, sh, or , sh + B , cells (, u00d7 , in , u03bcL PBS) were subcutaneously injected into each mouse as indicated. Tumors were measured using a digital caliper and the tumor volume was calculated by the formula: (width), u00d7 length/2. For establishing anti-, therapeutic mouse . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.